Bioceres Crop Solutions (NASDAQ:BIOX) Lifted to Strong-Buy at Roth Capital

Roth Capital upgraded shares of Bioceres Crop Solutions (NASDAQ:BIOX) to a strong-buy rating in a report released on Tuesday morning, Zacks.com reports. Roth Capital also issued estimates for Bioceres Crop Solutions’ Q4 2024 earnings at $0.19 EPS, FY2024 earnings at $0.31 EPS, Q1 2025 earnings at $0.21 EPS, Q2 2025 earnings at $0.21 EPS, Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.26 EPS, FY2025 earnings at $0.78 EPS and FY2026 earnings at $1.19 EPS.

Separately, Roth Mkm began coverage on Bioceres Crop Solutions in a research note on Tuesday. They set a buy rating and a $15.00 price objective on the stock.

Bioceres Crop Solutions Price Performance

BIOX stock opened at $11.20 on Tuesday. The stock has a 50-day moving average price of $11.31 and a two-hundred day moving average price of $12.45. Bioceres Crop Solutions has a 12-month low of $10.10 and a 12-month high of $14.05. The company has a current ratio of 1.22, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29. The company has a market cap of $703.36 million, a PE ratio of 1,120.00 and a beta of 0.50.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Wednesday, May 29th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The company had revenue of $83.98 million for the quarter, compared to analyst estimates of $88.80 million. As a group, research analysts predict that Bioceres Crop Solutions will post 0.36 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently modified their holdings of BIOX. Activest Wealth Management acquired a new stake in shares of Bioceres Crop Solutions in the first quarter worth $30,000. Cape Investment Advisory Inc. bought a new position in Bioceres Crop Solutions during the fourth quarter valued at about $33,000. Oppenheimer & Co. Inc. bought a new position in Bioceres Crop Solutions during the first quarter valued at about $139,000. Lazard Asset Management LLC bought a new position in shares of Bioceres Crop Solutions in the first quarter worth about $212,000. Finally, One Degree Advisors Inc bought a new position in shares of Bioceres Crop Solutions in the fourth quarter worth about $291,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.